Details
Title
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease
Author
Lund, Thomas 1
; Gundesen, Michael Tveden 1 ; Juul Vangsted, Annette 2
; Helleberg, Carsten 2 ; Haukås, Einar 3 ; Silkjær, Trine 4 ; Asmussen, Jon Thor 5
; Manuela Teodorescu, Elena 6 ; Amdi Jensen, Bo 7 ; Schmidt Slørdahl, Tobias 8
; Nahi, Hareth 9 ; Waage, Anders 8
; Abildgaard, Niels 1 ; Schjesvold, Fredrik 10
1 Odense University Hospital, Department of Hematology, Odense, Denmark (GRID:grid.7143.1) (ISNI:0000 0004 0512 5013); University of Southern Denmark, Department of Clinical Research, Odense, Denmark (GRID:grid.10825.3e) (ISNI:0000 0001 0728 0170)
2 Rigshospitalet, Department of Hematology, Copenhagen, Denmark (GRID:grid.475435.4)
3 Stavanger University Hospital, Department of Blood and Cancer Diseases, Stavanger, Norway (GRID:grid.412835.9) (ISNI:0000 0004 0627 2891)
4 Aarhus University Hospital, Department of Hematology, Aarhus, Denmark (GRID:grid.154185.c) (ISNI:0000 0004 0512 597X)
5 Odense University Hospital, Department of Radiology, Odense, Denmark (GRID:grid.7143.1) (ISNI:0000 0004 0512 5013)
6 Aalborg University Hospital, Department of Hematology, Aalborg, Denmark (GRID:grid.27530.33) (ISNI:0000 0004 0646 7349)
7 Zealand University Hospital, Department of Hematology, Roskilde, Denmark (GRID:grid.476266.7)
8 St. Olavs Hospital and Norwegian University of Science and Technology (NTNU), Department of Hematology, Trondheim, Norway (GRID:grid.5947.f) (ISNI:0000 0001 1516 2393)
9 Karolinska Institutet, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
10 Oslo University Hospital, Oslo Myeloma Center, Department of Hematology, Oslo, Norway (GRID:grid.55325.34) (ISNI:0000 0004 0389 8485); University of Oslo, K.G. Jebsen Centre for B-Cell Malignancies, Oslo, Norway (GRID:grid.5510.1) (ISNI:0000 0004 1936 8921)
; Gundesen, Michael Tveden 1 ; Juul Vangsted, Annette 2
; Helleberg, Carsten 2 ; Haukås, Einar 3 ; Silkjær, Trine 4 ; Asmussen, Jon Thor 5
; Manuela Teodorescu, Elena 6 ; Amdi Jensen, Bo 7 ; Schmidt Slørdahl, Tobias 8
; Nahi, Hareth 9 ; Waage, Anders 8
; Abildgaard, Niels 1 ; Schjesvold, Fredrik 10
1 Odense University Hospital, Department of Hematology, Odense, Denmark (GRID:grid.7143.1) (ISNI:0000 0004 0512 5013); University of Southern Denmark, Department of Clinical Research, Odense, Denmark (GRID:grid.10825.3e) (ISNI:0000 0001 0728 0170)
2 Rigshospitalet, Department of Hematology, Copenhagen, Denmark (GRID:grid.475435.4)
3 Stavanger University Hospital, Department of Blood and Cancer Diseases, Stavanger, Norway (GRID:grid.412835.9) (ISNI:0000 0004 0627 2891)
4 Aarhus University Hospital, Department of Hematology, Aarhus, Denmark (GRID:grid.154185.c) (ISNI:0000 0004 0512 597X)
5 Odense University Hospital, Department of Radiology, Odense, Denmark (GRID:grid.7143.1) (ISNI:0000 0004 0512 5013)
6 Aalborg University Hospital, Department of Hematology, Aalborg, Denmark (GRID:grid.27530.33) (ISNI:0000 0004 0646 7349)
7 Zealand University Hospital, Department of Hematology, Roskilde, Denmark (GRID:grid.476266.7)
8 St. Olavs Hospital and Norwegian University of Science and Technology (NTNU), Department of Hematology, Trondheim, Norway (GRID:grid.5947.f) (ISNI:0000 0001 1516 2393)
9 Karolinska Institutet, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
10 Oslo University Hospital, Oslo Myeloma Center, Department of Hematology, Oslo, Norway (GRID:grid.55325.34) (ISNI:0000 0004 0389 8485); University of Oslo, K.G. Jebsen Centre for B-Cell Malignancies, Oslo, Norway (GRID:grid.5510.1) (ISNI:0000 0004 1936 8921)
Pages
65
Publication year
2024
Publication date
Dec 2024
e-ISSN
20445385
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3038446471
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.